C3.ai sued for misleading investors on growth and CEO health.

• C3.ai sued for misleading investors on growth trajectory and CEO health. • Lawsuit alleges concealment of adverse facts. • Preliminary Q1 fiscal 2026 financial results fell short of expectations. • Revenue forecast lowered. • Investors with shares from Feb 26 to Aug 8 may seek lead plaintiff status by Oct 21.

C3.ai, Inc. (NYSE: AI) is facing a class action lawsuit alleging that the company misled investors about its financial health and growth prospects. The lawsuit, filed in the U.S. District Court for the Northern District of California, claims that C3.ai and its senior leadership violated the Securities Exchange Act of 1934 Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman^[2].

The complaint, filed under the caption Liggett v. C3.ai, Inc., alleges that the company projected an overly optimistic picture of its revenue and growth potential. Specifically, the lawsuit alleges that these projections downplayed the significant risk posed by CEO Thomas M. Siebel’s health issues. The plaintiffs contend that C3.ai's public statements on growth and profitability were "unrealistic" and depended too heavily on the health and performance of its chief executive Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman^[2].

The case focuses on a significant drop in stock price that followed C3.ai's financial announcement on August 8, 2025. On that date, the company disclosed preliminary first-quarter results that fell short of expectations and lowered its revenue guidance for the full fiscal year. C3.ai attributed these disappointing results to "reorganization with new leadership" and Siebel's health problems. Following this news, the stock price reportedly plummeted by more than 25% Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman^[2].

The lawsuit seeks to represent investors who purchased or acquired C3.ai securities during the specified class period, which runs from February 26, 2025, to August 8, 2025. Investors who suffered substantial losses and are interested in serving as a lead plaintiff must file a motion with the court no later than October 21, 2025 Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman^[2].

A separate class action lawsuit has also been filed by Bronstein, Gewirtz & Grossman, LLC, alleging similar violations of federal securities laws. This lawsuit claims that C3.ai made materially false and misleading statements and/or failed to disclose that the health of its CEO was materially impairing the Company’s ability to close deals and that management was unable to mitigate the impact of the CEO’s health on business operations AI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit^[1].

The preliminary Q1 fiscal 2026 financial results released by C3.ai fell short of expectations, with the company reporting a revenue of $70.26 million, which was significantly lower than analysts' estimates of $104.02 million. This resulted in a loss of (-$0.86) earnings per share. The stock price of C3.ai has been volatile, with insiders, including CFO Hitesh Lath and CEO Thomas M. Siebel, selling a combined total of 607,157 shares recently, reflecting a decrease in their ownership stakes 141,985 Shares in C3.ai, Inc. $AI Acquired by Acadian Asset Management LLC^[3].

Investors who believe they have suffered losses as a result of these alleged misstatements are encouraged to contact legal counsel to discuss their options. The deadline to request the Court appoint them as lead plaintiff is October 21, 2025 AI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that C3.ai, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit^[1]Investors Allege Misleading Statements in C3.ai (AI) Class Action Lawsuit-- Hagens Berman^[2].